LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 21 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,000 | -24.3% | 50,000 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $367,000 | +86.8% | 50,000 | 0.0% | 0.01% | +80.0% |
| Q1 2023 | $196,500 | +148.7% | 50,000 | +100.0% | 0.01% | +150.0% |
| Q4 2022 | $79,000 | -69.6% | 25,000 | -64.3% | 0.00% | -71.4% |
| Q3 2022 | $260,000 | +20.4% | 70,000 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $216,000 | -40.5% | 70,000 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $363,000 | +7.1% | 70,000 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $339,000 | -45.7% | 70,000 | 0.0% | 0.01% | -50.0% |
| Q3 2021 | $624,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |